Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion by Maria C. Kuppner, Anabel Scharner, Valeria.

Slides:



Advertisements
Similar presentations
Volume 114, Issue 4, Pages (April 1998)
Advertisements

Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype by Andreas C. Renkl, Julia Wussler,
Calcium Ionophore-Treated Myeloid Cells Acquire Many Dendritic Cell Characteristics Independent of Prior Differentiation State, Transformation Status,
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Involvement of suppressors of cytokine signaling in toll-like receptor–mediated block of dendritic cell differentiation by Holger Bartz, Nicole M. Avalos,
IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity.
by Kathryn Lagrue, Alex Carisey, David J
by JoAnn Castelli, Elaine K
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
by Jacob Rachmilewitz, Gregory J
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators by Rikke Bæk Sørensen, Sine Reker Hadrup, Inge Marie Svane, Mads Christian.
by Rui Zhang, Jeffrey D. Lifson, and Claire Chougnet
IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcγRIIa by Anna Smed-Sörensen, Markus Moll,
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment by Francis Mussai, Carmela De Santo, Issa Abu-Dayyeh, Sarah Booth,
Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines.
Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential by Norihiko Watanabe, Shino.
by Kirsteen H. Maclean, John L. Cleveland, and John B. Porter
Interaction of Sickle Erythrocytes With Endothelial Cells in the Presence of Endothelial Cell Conditioned Medium Induces Oxidant Stress Leading to Transendothelial.
Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells by Gerty Schreibelt,
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses by Madeleine M. Hipp, Norbert Hilf, Steffen.
by Norman Nausch, Ioanna E
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants by Georg.
Volume 130, Issue 2, Pages (February 2006)
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
Interleukin-21 is a growth and survival factor for human myeloma cells
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells by Elke Scandella, Ying Men, Silke Gillessen,
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA by Caterina Milazzo, Volker L. Reichardt, Martin.
Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte.
The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions by Markus P. Radsak, Norbert Hilf, Harpreet Singh-Jasuja,
by Éric Aubin, Réal Lemieux, and Renée Bazin
SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-κB activity, resulting in strong inhibition of osteoclast formation/activity and multiple.
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15 by Maria Wysocka, Bernice M. Benoit, Sarah.
Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion by Marie-Cécile Michallet, Frederic Saltel,
Cord Blood CD34+ Cells Differentiate into Dermal Dendritic Cells in Co-Culture with Cutaneous Fibroblasts or Stromal Cells  Zia U.A. Mollah, Setsuya Aiba,
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses by Cagan Gurer, Till.
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
Platelet-Derived Interleukin-1 Induces Cytokine Production, but not Proliferation of Human Vascular Smooth Muscle Cells by Harald Loppnow, Rosita Bil,
TGF-β combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion.
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15 by Lazar.
Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells by Thomas.
Interferon- Activates Multiple STAT Proteins and Upregulates Proliferation-Associated IL-2R, c-myc, and pim-1 Genes in Human T Cells by Sampsa Matikainen,
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease by Tangsheng Yi, Dongchang Zhao, Chia-Lei.
Volume 18, Issue 5, Pages (May 2003)
Norito Katoh, Fujiko Soga, Takeshi Nara, Koji Masuda, Saburo Kishimoto 
Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A  Satoshi Matsukura, MD, Fumio Kokubu,
Poly(I:C)-Treated Human Langerhans Cells Promote the Differentiation of CD4+ T Cells Producing IFN-γ and IL-10  Laetitia Furio, Hermine Billard, Jenny.
Induction of T-Cell Responses against Cutaneous T-Cell Lymphomas Ex Vivo by Autologous Dendritic Cells Transfected with Amplified Tumor mRNA  Xiao Ni,
Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm by Hew Yeng Lai, Stefan A. Brooks,
Fetal Calf Serum-Free Generation of Functionally Active Murine Dendritic Cells Suitable for In Vivo Therapeutic Approaches  Gabriele Müller, Anke Müller,
by Derek Hoi-Hang Ho, and Roger Hoi-Fung Wong
Liang Deng, Wanhong Ding, Richard D. Granstein 
Human CD4+ T Lymphocytes with Remarkable Regulatory Functions on Dendritic Cells and Nickel-Specific Th1 Immune Responses  Andrea Cavani, Francesca Nasorri,
Characterization of the Sensitizing Potential of Chemicals by In Vitro Analysis of Dendritic Cell Activation and Skin Penetration  Pierre Aeby, Christoph.
by Defne Bayik, Debra Tross, Lydia A
IL-12 affects Dermatophagoides farinae–induced IL-4 production by T cells from pediatric patients with mite-sensitive asthma  Takeshi Noma, MD, PhD, Izumi.
Human Beta-Defensin 3 Induces Maturation of Human Langerhans Cell–Like Dendritic Cells: An Antimicrobial Peptide that Functions as an Endogenous Adjuvant 
Ganglioside GQ1b enhances Ig production by human PBMCs
Serotonin Activates Human Monocytes and Prevents Apoptosis
Dimethylfumarate Induces Immunosuppression via Glutathione Depletion and Subsequent Induction of Heme Oxygenase 1  Joachim C.U. Lehmann, Joanna J. Listopad,
Volume 64, Issue 6, Pages (December 2003)
Regulation by Interleukin-10 and Interleukin-4 of Cyclooxygenase-2 Expression in Human Neutrophils by Hiroaki Niiro, Takeshi Otsuka, Kenji Izuhara, Kunihiro.
PD-1 blockade enhances T-cell function.
Inhibition of human allergic T-cell responses by IL-10–treated dendritic cells: Differences from hydrocortisone-treated dendritic cells  Iris Bellinghausen,
Figure 3 Fingolimod inhibits TNF-α secretion by human monocytes Peripheral blood mononuclear cells from healthy donors were briefly exposed to increasing.
T cell effector cytokines and staphylococcal products regulate CCL18.
Rapamycin inhibits IL-4—induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo by Holger Hackstein, Timucin Taner,
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
Presentation transcript:

Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion by Maria C. Kuppner, Anabel Scharner, Valeria Milani, Christoph von Hesler, Katharina E. Tschöp, Oksana Heinz, and Rolf D. Issels Blood Volume 102(10):3668-3674 November 15, 2003 ©2003 by American Society of Hematology

Reduction in intracellular GSH levels by 4-OH-IF. Reduction in intracellular GSH levels by 4-OH-IF. (A) T cells, NK cells, monocytes, immature DCs, and mature DCs (0.5 × 106/mL) were treated with 4-OH-IF (100 μM) for 90 minutes. Untreated cells were used as controls. Cells were then washed, and GSH levels were measured by HPLC. Results are expressed as nM GSH/mg protein, and they represent the mean ± SD from 3 separate donors. *P < .05; **P < .01. (B) T cells, NK cells, monocytes, immature DCs, and mature DCs (0.5 × 106/mL) were treated with increasing concentrations (50, 100, 200 μM) of 4-OH-IF for 90 minutes. Untreated cells were used as controls. Cells were then washed, and GSH levels were measured by HPLC. Results are expressed as the percentage of control values and represent the mean ± SD of 2 separate experiments from 2 separate donors. Maria C. Kuppner et al. Blood 2003;102:3668-3674 ©2003 by American Society of Hematology

Reconstitution of cellular GSH levels with GSH-OEt. Reconstitution of cellular GSH levels with GSH-OEt. T cells, NK cells, monocytes, immature DCs, and mature DCs (0.5 × 106/mL) were treated with 4-OH-IF (100 μM) for 90 minutes. GSH-OEt was added at a final concentration of 0.4 mM for 5 hours. Untreated cells were used as controls. Cells were then washed, and GSH levels were determined. Results are expressed as the percentage of control values and represent the mean ± SD from 3 separate experiments. *P < .05. Maria C. Kuppner et al. Blood 2003;102:3668-3674 ©2003 by American Society of Hematology

Effect of BSO on intracellular GSH levels. Effect of BSO on intracellular GSH levels. (A) T cells, NK cells, monocytes, immature DCs, and mature DCs (0.5 × 106/mL) were treated with BSO (5 mM) for 24 hours. Untreated cells were used as controls. Cells were then washed, and GSH levels were measured by HPLC. Results are expressed as nM GSH/mg protein and represent the mean ± SD from 3 separate experiments. *P < .05; **P < .01. (B) Cells were treated as in panel A, GSH-OEt was added at a final concentration of 0.4 mM for 5 hours, and GSH levels were measured by HPLC. Untreated cells were used as controls. Results are expressed as a percentage of control values and represent the mean ± SD from 3 separate experiments. (C) T cells, NK cells, monocytes, immature DCs, and mature DCs (0.5 × 106/mL) were treated with BSO (0.5 mM) for 24 hours. GSH-OEt was added at a final concentration of 5 mM for 5 hours. Cells were then washed, and GSH levels were determined. Untreated cells were used as controls. Results are expressed as the percentage of control values and represent the mean ± SD from 3 separate experiments. *P < .05; **P < .01. Maria C. Kuppner et al. Blood 2003;102:3668-3674 ©2003 by American Society of Hematology

Reduction in DC allostimulatory capacity after 4-OH-IF and BSO treatment and restoration with GSH-OEt. Reduction in DC allostimulatory capacity after 4-OH-IF and BSO treatment and restoration with GSH-OEt. (A) DCs were treated with 4-OH-IF (100 μM) alone for 90 minutes on day 8 or with 4-OH-IF for 90 minutes and then with GSH-OEt (0.4 mM) for 5 hours. Untreated cells from parallel day-8 cultures were used as controls. DCs were irradiated and incubated with PBLs (105/well) at different PBL/DC ratios for 6 days. Results are shown for the PBL/DC ratio of 32:1. *P < .05. (B) DCs were treated with BSO (0.5 mM) alone on day 7 for 24 hours or with BSO for 24 hours and then with GSH-OEt (5 mM) for 5 hours. DCs were irradiated and resuspended in RPMI medium plus 10% FCS and incubated with allogeneic PBLs (105/well) in 96-well plates at PBL/DC ratios ranging from 2:1 to 64:1 for 6 days. Results are shown for the PBL/DC ratio of 64:1. BSO-treated DCs alone, 4-OH-IF-treated DCs alone, untreated DCs alone, or PBLs alone were used as controls. The amount of [3H]-thymidine incorporated during the last 24 hours of culture was measured (A-B). Results are expressed as the mean ± SD of cpm values of triplicate cultures from 1 of 3 representative experiments. *P < .05. (C) 4-OH-IF and 4-OH-IF plus GSH-OEt-treated DCs and (D) BSO and BSO plus GSH-OEt-treated DCs were also washed, and GSH levels were measured by HPLC. Untreated cells were used as controls. Results are expressed as the percentage of control values and represent the mean ± SD from 3 treatments. *P < .05. Maria C. Kuppner et al. Blood 2003;102:3668-3674 ©2003 by American Society of Hematology

IFN-γ and IL-12p70 production are reduced in allogeneic cultures containing 4-OH-IF-treated DCs. DCs were treated with 4-OH-IF (100 μM) alone for 90 minutes on day 8 or with 4-OH-IF then GSH-OEt at a final concentration of 0.4 mM for 5 hours. IFN-γ and IL-12p70 production are reduced in allogeneic cultures containing 4-OH-IF-treated DCs. DCs were treated with 4-OH-IF (100 μM) alone for 90 minutes on day 8 or with 4-OH-IF then GSH-OEt at a final concentration of 0.4 mM for 5 hours. Untreated cells were used as controls. DCs were washed and resuspended in RPMI medium plus 10% FCS and incubated with allogeneic PBLs (105/well) in 96-well plates at different PBL/DC ratios for 6 days. Results are shown for the PBL/DC ratio of 64:1. Additional controls included DC alone, 4-OH-IF-treated DCs alone, or PBLs alone. Cell culture supernatants were collected after 6 days, and (A) IFN-γ and (B) IL-12p70 levels were determined using ELISA specific for each cytokine. Results in panel A represent the mean of triplicate samples ± SD from 3 separate experiments. Results in panel B represent the mean of triplicate samples ± SD from 1 experiment. *P < .05. Maria C. Kuppner et al. Blood 2003;102:3668-3674 ©2003 by American Society of Hematology

Ifosfamide reduces IL-12p70 production by LPS- and IFN-γ-stimulated DCs. (A).DCs were treated with 4-OH-IF for 90 minutes or with 4-OH-IF and then GSH-OEt at a final concentration of 0.4 mM for 5 hours. Ifosfamide reduces IL-12p70 production by LPS- and IFN-γ-stimulated DCs. (A).DCs were treated with 4-OH-IF for 90 minutes or with 4-OH-IF and then GSH-OEt at a final concentration of 0.4 mM for 5 hours. Untreated cells were used as controls. DCs at 5 × 104/well were then treated with 1 μg/mL LPS and 1 ng/mL IFN-γ for 24 hours, after which the supernatants were collected and IL-12p70 levels determined using ELISA. Results represent the mean ± SD of triplicate samples from 3 separate experiments. **P < .01. (B) 4-OH-IF- and 4-OH-IF plus GSH-OEt-treated DCs were washed, and GSH levels were measured by HPLC. Untreated cells were used as controls. Results are expressed as the percentage of control values and represent the mean ± SD from 3 treatments. **P < .01. Maria C. Kuppner et al. Blood 2003;102:3668-3674 ©2003 by American Society of Hematology

Ifosfamide and BSO have no effect on DC antigen-specific T-cell stimulation. Ifosfamide and BSO have no effect on DC antigen-specific T-cellstimulation. (A) DCs were cultured for 6 days in medium containing GM-CSF and IL-4 alone. TNF-α (800 U/mL) was added from days 6 to 8 of culture. BSO (0.5 mM) was added for 24 hours on day 7, and ifosfamide (100 μM) was added for 90 minutes on day 8. Treated and untreated DCs were then plated at 104/well in 100 μL medium in 96-well round-bottom plates and pulsed with tyrosinase peptide (1-10 μg/mL) for 2 hours. Tyrosinase-specific T cells (2 × 104) were then added in a final volume of 100 μL to each well in medium containing 20% FCS and 100 U/mL IL-2. Control cultures containing non-tyrosinase-pulsed DCs, DCs alone, or CTLs alone were also included. Supernatants (100 μL) were removed from each well after 24 hours and assayed for IFN-γ production using an ELISA kit specific for IFN-γ. Results represent the mean ± SD of triplicate samples from 1 of 3 representative experiments. (B) 4-OH-IF- or BSO-treated DCs were washed, and GSH levels were measured by HPLC. Untreated cells were used as controls. Results are expressed as the percentage of control values and represent the mean ± SD from 3 treatments. *P < .05. Maria C. Kuppner et al. Blood 2003;102:3668-3674 ©2003 by American Society of Hematology